For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.
Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.
Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...
Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...
University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback